X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Unichem Lab with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 UNICHEM LAB   MYLAN
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
MYLAN
Dec-14
UNICHEM LAB/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3824,285-   
Low Rs2343,019-   
Sales per share (Unadj.) Rs116.31,466.8-  
Earnings per share (Unadj.) Rs-18.9176.7-  
Cash flow per share (Unadj.) Rs-11.7284.4-  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %1.60-  
Book value per share (Unadj.) Rs381.0729.1-  
Shares outstanding (eoy) m70.34378.37-   
Bonus/Rights/Conversions BBOI-  
Price / Sales ratio x2.62.5 106.4%   
Avg P/E ratio x-16.320.7 -78.8%  
P/CF ratio (eoy) x-26.212.8 -204.4%  
Price / Book Value ratio x0.85.0 16.1%  
Dividend payout %-26.40-   
Avg Mkt Cap Rs m21,6681,381,812 1.6%   
No. of employees `0002.325.0 9.1%   
Total wages/salary Rs m2,0060-   
Avg. sales/employee Rs Th3,587.822,199.6 16.2%   
Avg. wages/employee Rs Th880.00-   
Avg. net profit/employee Rs Th-583.72,674.3 -21.8%   
INCOME DATA
Net Sales Rs m8,180554,991 1.5%  
Other income Rs m610-3,235 -18.9%   
Total revenues Rs m8,790551,756 1.6%   
Gross profit Rs m-1,320138,029 -1.0%  
Depreciation Rs m50540,762 1.2%   
Interest Rs m8023,939 0.3%   
Profit before tax Rs m-1,29570,093 -1.8%   
Minority Interest Rs m0-288 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m332,947 1.1%   
Profit after tax Rs m-1,33166,858 -2.0%  
Gross profit margin %-16.124.9 -64.9%  
Effective tax rate %-2.64.2 -61.4%   
Net profit margin %-16.312.0 -135.1%  
BALANCE SHEET DATA
Current assets Rs m23,318487,910 4.8%   
Current liabilities Rs m4,635381,448 1.2%   
Net working cap to sales %228.419.2 1,190.6%  
Current ratio x5.01.3 393.3%  
Inventory Days Days12278 156.0%  
Debtors Days Days121107 113.2%  
Net fixed assets Rs m8,163128,396 6.4%   
Share capital Rs m14119,626 0.7%   
"Free" reserves Rs m26,6600-   
Net worth Rs m26,801275,885 9.7%   
Long term debt Rs m3412,145 0.0%   
Total assets Rs m31,8901,111,240 2.9%  
Interest coverage x-15.23.9 -386.2%   
Debt to equity ratio x01.5 0.0%  
Sales to assets ratio x0.30.5 51.4%   
Return on assets %-3.98.2 -48.0%  
Return on equity %-5.024.2 -20.5%  
Return on capital %-4.513.6 -33.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m4,3560-   
CASH FLOW
From Operations Rs m-1,12372,954 -1.5%  
From Investments Rs m16,487-57,534 -28.7%  
From Financial Activity Rs m-8,811-19,223 45.8%  
Net Cashflow Rs m6,552-3,803 -172.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.89 Rs / USD

Compare UNICHEM LAB With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare UNICHEM LAB With: PLETHICO PHARMA  LUPIN LTD  FULFORD INDIA  ORCHID PHARMA LTD  SUVEN LIFE  



Today's Market

Sensex Ends 317 Points Higher; Realty and FMCG Stocks Witness Buying(Closing)

Indian share markets continued to trade on a positive note during closing hours of trade and ended the day on a strong note. Gains were largely seen in the realty sector and FMCG sector.

Related Views On News

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Nov 19, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS